When the South ‘Swings’ Together on Health Equity New Possibilities Emerge 01/07/2024 Elaine Ruth Fletcher While this week’s CARICOM summit in Grenada has been postponed due to Hurricane Beryl, when it does convenes, a key item on the agenda will be the new ‘HeDPAC’ initiative to deepen South-South partnerships to meet shared global health challenges – from pandemic threats to climate change. In remote communities of Guyana, the introduction of […] Continue reading -> Teach to Reach 10: Over 21,000 Health Workers Unite to Tackle Climate and Immunization Challenges 20/06/2024 Reda Sadki On June 20, 2024, over 21,000 health workers from more than 80 countries will attend the tenth edition of Teach to Reach, a two-day peer learning conference organized by the Geneva Learning Foundation. This event is not just another conference—it’s part of a growing movement that recognizes the power of local knowledge and action to […] Continue reading -> The Power of Partnerships in Advancing Global Health 29/05/2024 Maayan Hoffman GENEVA – Partnerships between industry, multilateral organizations, and other stakeholders are essential to overcoming challenges and improving access to innovations. This was the key message at an International Federation of Pharmaceutical Manufacturers (IFPMA) event on Tuesday evening, held on the sidelines of the World Health Assembly in Geneva. The gathering brought together representatives from the […] Continue reading -> WHO Updates List of Most Threatening Drug-Resistant Bacteria as Pharma Warns New Antibiotic Pipeline is Inadequate 17/05/2024 Kerry Cullinan The World Health Organization (WHO) has updated its list of antibiotic-resistant bacteria that pose the greatest threat to human health, ranking the 15 families of bacteria that feature as “critical”, “high” and “medium” threats. The Bacterial Priority Pathogens List (BPPL) 2024’s “critical” list features bacteria that are high burden, can resist treatment and spread resistance […] Continue reading -> Unlocking the Potential of Pharmacogenomics in Africa 25/04/2024 Kelly Chibale Pharmacogenomics research in Africa transcends mere regional healthcare improvements: it represents a pivotal step in addressing pressing global health challenges and propelling medical science forward for all. A revolution is sweeping through the field of medicine, redefining how we approach the treatment of diseases. Africa must not be left behind in this transformative journey. Pharmacogenomics, […] Continue reading -> Ensuring Ethical AI Implementation: HealthAI Launches Global Community of Practice 09/04/2024 Maayan Hoffman Artificial Intelligence (AI) can save lives – but “we need to get the regulations right,” according to Dr Ricardo Baptista Leite, CEO of HealthAI, the agency responsible for artificial intelligence in health. To address the urgent need for the robust regulation of AI in the healthcare sector, HealthAI has initiated a worldwide community of practice […] Continue reading -> Health As a Driver of Innovation Not Just a Recipient 03/04/2024 Hans Henri P. Kluge As WHO unveils S.A.R.A.H. (Smart AI Resource Assistant for Health), its new digital health promoter prototype powered by generative artificial intelligence (AI), and available in eight languages 24 hours a day, WHO’s Regional Director for Europe writes about harnessing innovation in health to help meet critical public health challenges, both now and in the future. […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
Teach to Reach 10: Over 21,000 Health Workers Unite to Tackle Climate and Immunization Challenges 20/06/2024 Reda Sadki On June 20, 2024, over 21,000 health workers from more than 80 countries will attend the tenth edition of Teach to Reach, a two-day peer learning conference organized by the Geneva Learning Foundation. This event is not just another conference—it’s part of a growing movement that recognizes the power of local knowledge and action to […] Continue reading -> The Power of Partnerships in Advancing Global Health 29/05/2024 Maayan Hoffman GENEVA – Partnerships between industry, multilateral organizations, and other stakeholders are essential to overcoming challenges and improving access to innovations. This was the key message at an International Federation of Pharmaceutical Manufacturers (IFPMA) event on Tuesday evening, held on the sidelines of the World Health Assembly in Geneva. The gathering brought together representatives from the […] Continue reading -> WHO Updates List of Most Threatening Drug-Resistant Bacteria as Pharma Warns New Antibiotic Pipeline is Inadequate 17/05/2024 Kerry Cullinan The World Health Organization (WHO) has updated its list of antibiotic-resistant bacteria that pose the greatest threat to human health, ranking the 15 families of bacteria that feature as “critical”, “high” and “medium” threats. The Bacterial Priority Pathogens List (BPPL) 2024’s “critical” list features bacteria that are high burden, can resist treatment and spread resistance […] Continue reading -> Unlocking the Potential of Pharmacogenomics in Africa 25/04/2024 Kelly Chibale Pharmacogenomics research in Africa transcends mere regional healthcare improvements: it represents a pivotal step in addressing pressing global health challenges and propelling medical science forward for all. A revolution is sweeping through the field of medicine, redefining how we approach the treatment of diseases. Africa must not be left behind in this transformative journey. Pharmacogenomics, […] Continue reading -> Ensuring Ethical AI Implementation: HealthAI Launches Global Community of Practice 09/04/2024 Maayan Hoffman Artificial Intelligence (AI) can save lives – but “we need to get the regulations right,” according to Dr Ricardo Baptista Leite, CEO of HealthAI, the agency responsible for artificial intelligence in health. To address the urgent need for the robust regulation of AI in the healthcare sector, HealthAI has initiated a worldwide community of practice […] Continue reading -> Health As a Driver of Innovation Not Just a Recipient 03/04/2024 Hans Henri P. Kluge As WHO unveils S.A.R.A.H. (Smart AI Resource Assistant for Health), its new digital health promoter prototype powered by generative artificial intelligence (AI), and available in eight languages 24 hours a day, WHO’s Regional Director for Europe writes about harnessing innovation in health to help meet critical public health challenges, both now and in the future. […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
The Power of Partnerships in Advancing Global Health 29/05/2024 Maayan Hoffman GENEVA – Partnerships between industry, multilateral organizations, and other stakeholders are essential to overcoming challenges and improving access to innovations. This was the key message at an International Federation of Pharmaceutical Manufacturers (IFPMA) event on Tuesday evening, held on the sidelines of the World Health Assembly in Geneva. The gathering brought together representatives from the […] Continue reading -> WHO Updates List of Most Threatening Drug-Resistant Bacteria as Pharma Warns New Antibiotic Pipeline is Inadequate 17/05/2024 Kerry Cullinan The World Health Organization (WHO) has updated its list of antibiotic-resistant bacteria that pose the greatest threat to human health, ranking the 15 families of bacteria that feature as “critical”, “high” and “medium” threats. The Bacterial Priority Pathogens List (BPPL) 2024’s “critical” list features bacteria that are high burden, can resist treatment and spread resistance […] Continue reading -> Unlocking the Potential of Pharmacogenomics in Africa 25/04/2024 Kelly Chibale Pharmacogenomics research in Africa transcends mere regional healthcare improvements: it represents a pivotal step in addressing pressing global health challenges and propelling medical science forward for all. A revolution is sweeping through the field of medicine, redefining how we approach the treatment of diseases. Africa must not be left behind in this transformative journey. Pharmacogenomics, […] Continue reading -> Ensuring Ethical AI Implementation: HealthAI Launches Global Community of Practice 09/04/2024 Maayan Hoffman Artificial Intelligence (AI) can save lives – but “we need to get the regulations right,” according to Dr Ricardo Baptista Leite, CEO of HealthAI, the agency responsible for artificial intelligence in health. To address the urgent need for the robust regulation of AI in the healthcare sector, HealthAI has initiated a worldwide community of practice […] Continue reading -> Health As a Driver of Innovation Not Just a Recipient 03/04/2024 Hans Henri P. Kluge As WHO unveils S.A.R.A.H. (Smart AI Resource Assistant for Health), its new digital health promoter prototype powered by generative artificial intelligence (AI), and available in eight languages 24 hours a day, WHO’s Regional Director for Europe writes about harnessing innovation in health to help meet critical public health challenges, both now and in the future. […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
WHO Updates List of Most Threatening Drug-Resistant Bacteria as Pharma Warns New Antibiotic Pipeline is Inadequate 17/05/2024 Kerry Cullinan The World Health Organization (WHO) has updated its list of antibiotic-resistant bacteria that pose the greatest threat to human health, ranking the 15 families of bacteria that feature as “critical”, “high” and “medium” threats. The Bacterial Priority Pathogens List (BPPL) 2024’s “critical” list features bacteria that are high burden, can resist treatment and spread resistance […] Continue reading -> Unlocking the Potential of Pharmacogenomics in Africa 25/04/2024 Kelly Chibale Pharmacogenomics research in Africa transcends mere regional healthcare improvements: it represents a pivotal step in addressing pressing global health challenges and propelling medical science forward for all. A revolution is sweeping through the field of medicine, redefining how we approach the treatment of diseases. Africa must not be left behind in this transformative journey. Pharmacogenomics, […] Continue reading -> Ensuring Ethical AI Implementation: HealthAI Launches Global Community of Practice 09/04/2024 Maayan Hoffman Artificial Intelligence (AI) can save lives – but “we need to get the regulations right,” according to Dr Ricardo Baptista Leite, CEO of HealthAI, the agency responsible for artificial intelligence in health. To address the urgent need for the robust regulation of AI in the healthcare sector, HealthAI has initiated a worldwide community of practice […] Continue reading -> Health As a Driver of Innovation Not Just a Recipient 03/04/2024 Hans Henri P. Kluge As WHO unveils S.A.R.A.H. (Smart AI Resource Assistant for Health), its new digital health promoter prototype powered by generative artificial intelligence (AI), and available in eight languages 24 hours a day, WHO’s Regional Director for Europe writes about harnessing innovation in health to help meet critical public health challenges, both now and in the future. […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
Unlocking the Potential of Pharmacogenomics in Africa 25/04/2024 Kelly Chibale Pharmacogenomics research in Africa transcends mere regional healthcare improvements: it represents a pivotal step in addressing pressing global health challenges and propelling medical science forward for all. A revolution is sweeping through the field of medicine, redefining how we approach the treatment of diseases. Africa must not be left behind in this transformative journey. Pharmacogenomics, […] Continue reading -> Ensuring Ethical AI Implementation: HealthAI Launches Global Community of Practice 09/04/2024 Maayan Hoffman Artificial Intelligence (AI) can save lives – but “we need to get the regulations right,” according to Dr Ricardo Baptista Leite, CEO of HealthAI, the agency responsible for artificial intelligence in health. To address the urgent need for the robust regulation of AI in the healthcare sector, HealthAI has initiated a worldwide community of practice […] Continue reading -> Health As a Driver of Innovation Not Just a Recipient 03/04/2024 Hans Henri P. Kluge As WHO unveils S.A.R.A.H. (Smart AI Resource Assistant for Health), its new digital health promoter prototype powered by generative artificial intelligence (AI), and available in eight languages 24 hours a day, WHO’s Regional Director for Europe writes about harnessing innovation in health to help meet critical public health challenges, both now and in the future. […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
Ensuring Ethical AI Implementation: HealthAI Launches Global Community of Practice 09/04/2024 Maayan Hoffman Artificial Intelligence (AI) can save lives – but “we need to get the regulations right,” according to Dr Ricardo Baptista Leite, CEO of HealthAI, the agency responsible for artificial intelligence in health. To address the urgent need for the robust regulation of AI in the healthcare sector, HealthAI has initiated a worldwide community of practice […] Continue reading -> Health As a Driver of Innovation Not Just a Recipient 03/04/2024 Hans Henri P. Kluge As WHO unveils S.A.R.A.H. (Smart AI Resource Assistant for Health), its new digital health promoter prototype powered by generative artificial intelligence (AI), and available in eight languages 24 hours a day, WHO’s Regional Director for Europe writes about harnessing innovation in health to help meet critical public health challenges, both now and in the future. […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
Health As a Driver of Innovation Not Just a Recipient 03/04/2024 Hans Henri P. Kluge As WHO unveils S.A.R.A.H. (Smart AI Resource Assistant for Health), its new digital health promoter prototype powered by generative artificial intelligence (AI), and available in eight languages 24 hours a day, WHO’s Regional Director for Europe writes about harnessing innovation in health to help meet critical public health challenges, both now and in the future. […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts